Role of Prebiotics and Probiotics in the Protection Against Cervical Cancers

Authors:
  • SGSubhrojyoti Ghosh
    Subhrojyoti Ghosh
  • ADAnuvab Dey
    Anuvab Dey
  • SMSourav Majhi
    Sourav Majhi
  • SBSuman Barua
    Suman Barua
  • ABAishi Bera
    Aishi Bera
  • SHSubhranil Hazra
    Subhranil Hazra

Abstract
Worldwide, cervical cancer is regarded as a significant cancer that affects women. According to reports, patients who receive current cervical cancer treatments experience cytotoxicity. Additionally, these treatments have manifested unfavorable side effects that may shorten women’s lives with this illness. Therefore, fewer hazardous anti-tumor medicines are required than conventional therapeutic treatments. Furthermore, cervical cancer patients’ quality of life may be improved by using drugs that prevent or lessen the negative effects of their treatments. Numerous health advantages of probiotic supplements, frequently including live bacteria, have been well-researched in studies. Major research areas have included the impact of probiotic supplements on chemotherapy toxicity and effectiveness, as well as cancer prevention. The 136usefulness of probiotics used to treat cervical cancer has recently attracted attention among various studies. Including prebiotics, indigestible compounds broken down by gut microbiota, can increase the effectiveness of probiotics on human health. Prebiotics are fermentable and nondigestible carbohydrates that preferentially affect the development of probiotic organisms, which inhibit malignant cell development through immunomodulation. By attracting natural killer cells and cytotoxic T cells, and triggering apoptosis through oxidative stress in the tumor microenvironment, bacteria are able to suppress tumor growth. This book chapter reviews the microorganisms utilized as probiotics, either alone or in conjunction with prebiotics or medications, to lessen the unintended consequences of cervical cancer therapy.